1. Home
  2. TIL vs NEWP Comparison

TIL vs NEWP Comparison

Compare TIL & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • NEWP
  • Stock Information
  • Founded
  • TIL 2018
  • NEWP 1972
  • Country
  • TIL United States
  • NEWP Canada
  • Employees
  • TIL N/A
  • NEWP N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • NEWP
  • Sector
  • TIL Health Care
  • NEWP
  • Exchange
  • TIL Nasdaq
  • NEWP Nasdaq
  • Market Cap
  • TIL 171.7M
  • NEWP 199.1M
  • IPO Year
  • TIL 2021
  • NEWP N/A
  • Fundamental
  • Price
  • TIL $13.23
  • NEWP $1.17
  • Analyst Decision
  • TIL Buy
  • NEWP Strong Buy
  • Analyst Count
  • TIL 5
  • NEWP 1
  • Target Price
  • TIL $114.00
  • NEWP $5.00
  • AVG Volume (30 Days)
  • TIL 180.4K
  • NEWP 207.4K
  • Earning Date
  • TIL 05-20-2025
  • NEWP 05-07-2025
  • Dividend Yield
  • TIL N/A
  • NEWP N/A
  • EPS Growth
  • TIL N/A
  • NEWP N/A
  • EPS
  • TIL N/A
  • NEWP N/A
  • Revenue
  • TIL N/A
  • NEWP N/A
  • Revenue This Year
  • TIL N/A
  • NEWP N/A
  • Revenue Next Year
  • TIL N/A
  • NEWP N/A
  • P/E Ratio
  • TIL N/A
  • NEWP N/A
  • Revenue Growth
  • TIL N/A
  • NEWP N/A
  • 52 Week Low
  • TIL $9.62
  • NEWP $0.93
  • 52 Week High
  • TIL $92.00
  • NEWP $2.53
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.22
  • NEWP 51.25
  • Support Level
  • TIL $11.97
  • NEWP $1.13
  • Resistance Level
  • TIL $14.67
  • NEWP $1.20
  • Average True Range (ATR)
  • TIL 2.05
  • NEWP 0.06
  • MACD
  • TIL -0.04
  • NEWP -0.00
  • Stochastic Oscillator
  • TIL 17.87
  • NEWP 53.33

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

Share on Social Networks: